Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
31,870,536
-
Shares change
-
+11,642,033
-
Total reported value, excl. options
-
$551,351,062
-
Value change
-
+$204,323,240
-
Put/Call ratio
-
11.05%
-
Number of buys
-
57
-
Number of sells
-
-19
-
Price
-
$17.3
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q2 2017
99 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q2 2017.
NovoCure Ltd - Common Stock (NVCR) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,870,536 shares
of 111,111,111 outstanding shares and own 28.68% of the company stock.
Largest 10 shareholders include FMR LLC (6,888,120 shares), GOLDMAN SACHS GROUP INC (4,988,007 shares), VANGUARD GROUP INC (4,283,862 shares), BlackRock Inc. (3,793,118 shares), StepStone Group LP (1,815,479 shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1,735,810 shares), RHENMAN & PARTNERS ASSET MANAGEMENT AB (1,216,314 shares), STATE STREET CORP (1,082,589 shares), PEREGRINE CAPITAL MANAGEMENT LLC (846,036 shares), and FRONTIER CAPITAL MANAGEMENT CO LLC (827,054 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.